Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 91 | 1 | 7 | 0 | €1,056.8 | €1,087.1 | 2.868% |
| Boston Scientific | 77 | 0 | 11 | 0 | €44.39 | €83.22 | 87.498% |
| UnitedHealth Group Inc. | 76 | 2 | 11 | 0 | €350.20 | €368.94 | 5.351% |
| Intuitive Surgical Inc | 72 | 2 | 15 | 0 | €347.05 | €512.03 | 47.537% |
| Abbott Laboratories | 69 | 0 | 8 | 0 | €94.90 | €114.37 | 20.517% |
| Gilead Sciences Inc | 67 | 0 | 4 | 0 | €118.50 | €128.68 | 8.588% |
| Johnson & Johnson | 57 | 0 | 10 | 0 | €224.40 | €228.39 | 1.779% |
| HCA Holdings Inc. | 55 | 2 | 7 | 1 | €358.70 | €435.61 | 21.443% |
| Dexcom Inc. | 53 | 2 | 10 | 0 | €76.80 | €75.81 | -1.289% |
| AbbVie Inc. | 46 | 0 | 5 | 0 | €216.10 | €228.85 | 5.901% |
| Regeneron Pharmaceuticals Inc. | 45 | 0 | 4 | 0 | €700.00 | €730.15 | 4.307% |
| Biogen Inc. | 42 | 1 | 9 | 0 | €178.60 | €203.01 | 13.670% |
| Vertex Pharmaceuticals Inc. | 42 | 1 | 4 | 0 | €460.20 | €475.00 | 3.216% |
| Medtronic plc | 41 | 1 | 1 | 0 | €78.08 | €97.41 | 24.750% |
| Amgen Inc. | 42 | 4 | 7 | 2 | €357.85 | €340.76 | -4.776% |
| Agilent Technologies Inc. | 34 | 0 | 1 | 0 | €129.50 | €137.44 | 6.131% |
| Cigna Corp. | 32 | 0 | 1 | 0 | €241.20 | €286.34 | 18.716% |
| Edwards Lifesciences Corp. | 31 | 0 | 7 | 0 | €81.00 | €85.42 | 5.457% |
| Thermo Fisher Scientific Inc. | 30 | 0 | 1 | 0 | €519.80 | €538.69 | 3.634% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 3 | 0 | €60.04 | €73.11 | 21.773% |
| Stryker Corp. | 27 | 0 | 5 | 0 | €301.30 | €350.80 | 16.427% |
| Merck & Co. Inc. | 26 | 0 | 6 | 0 | €112.96 | €122.85 | 8.755% |
| Humana Inc. | 32 | 7 | 8 | 0 | €328.00 | €186.51 | -43.136% |
| Incyte Corp. | 25 | 1 | 7 | 0 | €104.60 | €114.79 | 9.746% |
| Elanco Animal Health Inc. | 24 | 0 | 2 | 0 | €19.84 | €25.33 | 27.683% |